ID   B3GN6_HUMAN             Reviewed;         384 AA.
AC   Q6ZMB0; E9PKS1; Q6ZSC5; Q8TAZ4; Q8TDX1;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   29-MAY-2007, sequence version 2.
DT   10-MAY-2017, entry version 97.
DE   RecName: Full=Acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase;
DE            EC=2.4.1.147 {ECO:0000269|PubMed:7655172};
DE   AltName: Full=Core 3 synthase;
DE   AltName: Full=UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6;
DE            Short=BGnT-6;
DE            Short=Beta-1,3-Gn-T6;
DE            Short=Beta-1,3-N-acetylglucosaminyltransferase 6;
DE            Short=Beta3Gn-T6;
GN   Name=B3GNT6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=11821425; DOI=10.1074/jbc.M112457200;
RA   Iwai T., Inaba N., Naundorf A., Zhang Y., Gotoh M., Iwasaki H.,
RA   Kudo T., Togayachi A., Ishizuka Y., Nakanishi H., Narimatsu H.;
RT   "Molecular cloning and characterization of a novel UDP-GlcNAc:GalNAc-
RT   peptide beta1,3-N-acetylglucosaminyltransferase (beta 3Gn-T6), an
RT   enzyme synthesizing the core 3 structure of O-glycans.";
RL   J. Biol. Chem. 277:12802-12809(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Ileal mucosa;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBSTRATE
RP   SPECIFICITY.
RX   PubMed=7655172; DOI=10.1093/glycob/5.3.351;
RA   Vavasseur F., Yang J.M., Dole K., Paulsen H., Brockhausen I.;
RT   "Synthesis of O-glycan core 3: characterization of UDP-GlcNAc: GalNAc-
RT   R beta 3-N-acetyl-glucosaminyltransferase activity from colonic
RT   mucosal tissues and lack of the activity in human cancer cell lines.";
RL   Glycobiology 5:351-357(1995).
RN   [6]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15755813; DOI=10.1073/pnas.0407983102;
RA   Iwai T., Kudo T., Kawamoto R., Kubota T., Togayachi A., Hiruma T.,
RA   Okada T., Kawamoto T., Morozumi K., Narimatsu H.;
RT   "Core 3 synthase is down-regulated in colon carcinoma and profoundly
RT   suppresses the metastatic potential of carcinoma cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:4572-4577(2005).
CC   -!- FUNCTION: Beta-1,3-N-acetylglucosaminyltransferase that
CC       synthesizes the core 3 structure of the O-glycan, an important
CC       precursor in the biosynthesis of mucin-type glycoproteins. Plays
CC       an important role in the synthesis of mucin-type O-glycans in
CC       digestive organs.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-glucosamine + O(3)-(N-
CC       acetyl-alpha-D-galactosaminyl)-L-threonyl/L-seryl-[protein] = UDP
CC       + O(3)-(N-acetyl-beta-D-glucosaminyl-(1->3)-N-acetyl-alpha-D-
CC       galactosaminyl)-L-threonyl/L-seryl-[protein].
CC       {ECO:0000269|PubMed:7655172}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3.3 mM for GalNAc-alpha-Bn {ECO:0000269|PubMed:7655172};
CC         Vmax=4.5 nmol/h/mg enzyme with GalNAc-alpha-Bn as substrate
CC         {ECO:0000269|PubMed:7655172};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000269|PubMed:15755813}; Single-pass type II membrane
CC       protein {ECO:0000269|PubMed:15755813}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q6ZMB0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6ZMB0-2; Sequence=VSP_025963, VSP_025964;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q6ZMB0-3; Sequence=VSP_047091;
CC         Note=Gene prediction based on EST data.;
CC   -!- TISSUE SPECIFICITY: Present in stomach and colon (at protein
CC       level). Restricted in the stomach, colon and small intestine,
CC       where core 3 structure is present. {ECO:0000269|PubMed:15755813}.
CC   -!- INDUCTION: Down-regulated in gastric and colorectal carcinomas,
CC       suggesting that it may be used as a marker for distinguishing
CC       between benign adenomas and premalignant lesions (at protein
CC       level).
CC   -!- MISCELLANEOUS: Injection into nude mice significantly suppress
CC       lung metastasis, indicating that the core structures of O-glycans
CC       are profoundly involved in the metastatic capacity of cancer
CC       cells.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 31 family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/B3GNT6ID44427ch11q13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB073740; BAB88882.1; -; mRNA.
DR   EMBL; AK127544; BAC87028.1; -; mRNA.
DR   EMBL; AK172863; BAD18819.1; -; mRNA.
DR   EMBL; AP000752; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC025357; AAH25357.1; -; mRNA.
DR   EMBL; BC103908; AAI03909.1; -; mRNA.
DR   EMBL; BC103909; AAI03910.1; -; mRNA.
DR   EMBL; BC103910; AAI03911.1; -; mRNA.
DR   CCDS; CCDS53681.1; -. [Q6ZMB0-1]
DR   RefSeq; NP_619651.3; NM_138706.4. [Q6ZMB0-1]
DR   UniGene; Hs.352622; -.
DR   ProteinModelPortal; Q6ZMB0; -.
DR   ChEMBL; CHEMBL2321631; -.
DR   CAZy; GT31; Glycosyltransferase Family 31.
DR   iPTMnet; Q6ZMB0; -.
DR   PhosphoSitePlus; Q6ZMB0; -.
DR   DMDM; 152033628; -.
DR   PaxDb; Q6ZMB0; -.
DR   PeptideAtlas; Q6ZMB0; -.
DR   PRIDE; Q6ZMB0; -.
DR   DNASU; 192134; -.
DR   Ensembl; ENST00000622824; ENSP00000484640; ENSG00000198488. [Q6ZMB0-1]
DR   GeneID; 192134; -.
DR   KEGG; hsa:192134; -.
DR   UCSC; uc031xwa.2; human. [Q6ZMB0-1]
DR   CTD; 192134; -.
DR   DisGeNET; 192134; -.
DR   GeneCards; B3GNT6; -.
DR   H-InvDB; HIX0026120; -.
DR   HGNC; HGNC:24141; B3GNT6.
DR   HPA; HPA012158; -.
DR   HPA; HPA039805; -.
DR   MIM; 615315; gene.
DR   neXtProt; NX_Q6ZMB0; -.
DR   OpenTargets; ENSG00000198488; -.
DR   PharmGKB; PA164741288; -.
DR   eggNOG; KOG2287; Eukaryota.
DR   eggNOG; ENOG410ZZ1B; LUCA.
DR   GeneTree; ENSGT00760000118879; -.
DR   HOGENOM; HOG000232195; -.
DR   HOVERGEN; HBG050653; -.
DR   InParanoid; Q6ZMB0; -.
DR   KO; K00739; -.
DR   OMA; RFAPYEM; -.
DR   OrthoDB; EOG091G0AXM; -.
DR   PhylomeDB; Q6ZMB0; -.
DR   TreeFam; TF318639; -.
DR   BRENDA; 2.4.1.147; 2681.
DR   Reactome; R-HSA-913709; O-linked glycosylation of mucins.
DR   UniPathway; UPA00378; -.
DR   GenomeRNAi; 192134; -.
DR   PRO; PR:Q6ZMB0; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000198488; -.
DR   CleanEx; HS_B3GNT6; -.
DR   ExpressionAtlas; Q6ZMB0; baseline and differential.
DR   Genevisible; Q6ZMB0; HS.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; NAS:UniProtKB.
DR   GO; GO:0047224; F:acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0047223; F:beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity; NAS:UniProtKB.
DR   GO; GO:0008378; F:galactosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0008499; F:UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; TAS:Reactome.
DR   GO; GO:0009101; P:glycoprotein biosynthetic process; NAS:UniProtKB.
DR   GO; GO:0016266; P:O-glycan processing; TAS:Reactome.
DR   GO; GO:0016269; P:O-glycan processing, core 3; NAS:UniProtKB.
DR   InterPro; IPR002659; Glyco_trans_31.
DR   PANTHER; PTHR11214; PTHR11214; 1.
DR   Pfam; PF01762; Galactosyl_T; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Glycoprotein;
KW   Glycosyltransferase; Golgi apparatus; Membrane; Reference proteome;
KW   Signal-anchor; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    384       Acetylgalactosaminyl-O-glycosyl-
FT                                glycoprotein beta-1,3-N-
FT                                acetylglucosaminyltransferase.
FT                                /FTId=PRO_0000289218.
FT   TOPO_DOM      1     12       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     13     31       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     32    384       Lumenal. {ECO:0000255}.
FT   CARBOHYD     73     73       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     77     77       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    196    196       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ      25    147       ALQQWFLQAPRSPREERSPQEETPEGPTDAPAADEPPSELV
FT                                PGPPCVANASANATADFEQLPARIQDFLRYRHCRHFPLLWD
FT                                APAKCAGGRGVFLLLAVKSAPEHYERRELIRRTWGQERSYG
FT                                -> VLQRRRLPPVRPHGPGPARGRPPHPALPHRRRLH (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_025963.
FT   VAR_SEQ     289    319       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_025964.
FT   VAR_SEQ     317    335       ERAGLAPSGHEGIRPFGVQ -> GARRPGAQRPRGHPGPSA
FT                                CS (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_047091.
FT   CONFLICT    164    164       D -> N (in Ref. 2; BAD18819).
FT                                {ECO:0000305}.
FT   CONFLICT    191    191       A -> T (in Ref. 4; AAH25357).
FT                                {ECO:0000305}.
SQ   SEQUENCE   384 AA;  42748 MW;  F76C4577D3008429 CRC64;
     MAFPCRRSLT AKTLACLLVG VSFLALQQWF LQAPRSPREE RSPQEETPEG PTDAPAADEP
     PSELVPGPPC VANASANATA DFEQLPARIQ DFLRYRHCRH FPLLWDAPAK CAGGRGVFLL
     LAVKSAPEHY ERRELIRRTW GQERSYGGRP VRRLFLLGTP GPEDEARAER LAELVALEAR
     EHGDVLQWAF ADTFLNLTLK HLHLLDWLAA RCPHARFLLS GDDDVFVHTA NVVRFLQAQP
     PGRHLFSGQL MEGSVPIRDS WSKYFVPPQL FPGSAYPVYC SGGGFLLSGP TARALRAAAR
     HTPLFPIDDA YMGMCLERAG LAPSGHEGIR PFGVQLPGAQ QSSFDPCMYR ELLLVHRFAP
     YEMLLMWKAL HSPALSCDRG HRVS
//
